Case Study: a global pharmaceutical company builds a data-centric R&D strategy with Astrix

a global pharmaceutical company evaluates 40+ vendors to build a data-centric R&D strategy with Astrix

A global pharmaceutical company faced challenges in its R&D operations due to a decentralized technology approach that had resulted from decades of acquisitions. This led to significant system duplication and inconsistent data, hindering global collaboration. To fuel its next stage of growth, the company engaged Astrix to develop a comprehensive, data-centric technology strategy.

Astrix implemented a phased project to design a modern, platform-based architecture. They first defined the necessary business capabilities and logical platforms before evolving a technical architecture and evaluating over 40 technology vendors. This process resulted in a detailed strategy and roadmap for execution. The result was a comprehensive strategy document designed to provide the right data to the right people at the right time, enabling enhanced interchange and collaboration with external partners.

Global Pharmaceutical Company